Core Laboratories (CLB) Projected to Release Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) is expected to be releasing its Q2 2025 earnings data after the market closes on Wednesday, July 23rd. Analysts expect the company to announce earnings of $0.18 per share and revenue of $129.19 million for the quarter. Core Laboratories has set its Q2 2025 guidance at 0.170-0.210 EPS.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, April 23rd. The oil and gas company reported $0.14 earnings per share for the quarter, missing the consensus estimate of $0.15 by ($0.01). Core Laboratories had a return on equity of 15.06% and a net margin of 5.41%. The firm had revenue of $123.59 million for the quarter, compared to the consensus estimate of $125.09 million. During the same period in the prior year, the company posted $0.19 earnings per share. Core Laboratories’s quarterly revenue was down 4.7% compared to the same quarter last year. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Trading Down 6.0%

Shares of CLB opened at $11.70 on Wednesday. The stock has a fifty day moving average price of $11.82 and a two-hundred day moving average price of $14.20. The company has a market cap of $548.26 million, a price-to-earnings ratio of 19.82, a PEG ratio of 3.83 and a beta of 1.41. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.64 and a current ratio of 2.21. Core Laboratories has a 52-week low of $10.14 and a 52-week high of $25.13.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, May 27th. Investors of record on Monday, May 5th were given a $0.01 dividend. This represents a $0.04 annualized dividend and a yield of 0.34%. The ex-dividend date was Monday, May 5th. Core Laboratories’s dividend payout ratio (DPR) is presently 6.78%.

Hedge Funds Weigh In On Core Laboratories

An institutional investor recently raised its position in Core Laboratories stock. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Core Laboratories Inc. (NYSE:CLB) by 4.4% during the 1st quarter, according to its most recent disclosure with the SEC. The institutional investor owned 27,893 shares of the oil and gas company’s stock after acquiring an additional 1,170 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. owned approximately 0.06% of Core Laboratories worth $418,000 as of its most recent filing with the SEC. 97.81% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities analysts have issued reports on CLB shares. Stifel Nicolaus reduced their target price on Core Laboratories from $19.00 to $15.00 and set a “hold” rating on the stock in a report on Tuesday, April 15th. Citigroup reduced their target price on shares of Core Laboratories from $16.00 to $13.00 and set a “neutral” rating for the company in a report on Tuesday, May 13th. Finally, Wall Street Zen cut Core Laboratories from a “hold” rating to a “sell” rating in a research note on Friday, April 25th.

About Core Laboratories

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.